-transparent.png){kind=logo}
Ten patients with rheumatoid arthritis were given identical amounts of conventional aspirin (Magnecyl) tablets and micro-encapsulated aspirin (Reumyl) capsules. Steady-state salicylate levels were determined after 4 days' treatment at 8 a.m., 12 noon, 4 p.m., 10 p.m. and again at 8 a.m. No difference was noted between the levels at 12 noon or 4 p.m. The 10 p.m. levels were slightly though not significantly higher and the last set of 8 a.m. levels were significantly higher during the capsule administration. A criterion for inclusion was good tolerance of Magnecyl. The clinical effectiveness was not evaluated, but the observed good absorption features of Reumyl indicate that this preparation may prove to be of value in long-term treatment.
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
November 1975,
The British journal of clinical practice,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
May 1976,
Rheumatology and rehabilitation,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
August 1970,
The Medical journal of Australia,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
October 1970,
The Medical journal of Australia,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
July 1970,
The Medical journal of Australia,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
January 1976,
The Journal of international medical research,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
April 1979,
British journal of clinical pharmacology,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
January 1980,
Current medical research and opinion,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
February 1984,
British journal of rheumatology,
A Hanson, and
Y Lindroth, and
K G Sjöblom, and
F A Wollheim
April 1982,
Arthritis and rheumatism,
